Preface |
|
v | |
|
|
xix | |
|
Chapter 1 Adult Stem Cells: From Bench-Top to Bedside |
|
|
1 | (60) |
|
|
|
|
|
|
2 | (4) |
|
2 Classification of Stem Cells |
|
|
6 | (13) |
|
3 Stem Cell Isolation and Cultivation |
|
|
19 | (7) |
|
|
19 | (1) |
|
|
19 | (1) |
|
|
20 | (1) |
|
|
21 | (1) |
|
3.5 Assaying for cell type |
|
|
22 | (4) |
|
4 Parkinson Disease and Potential of Stem Cell |
|
|
26 | (24) |
|
4.1 Bench-top animal model for Parkinson disease |
|
|
35 | (3) |
|
4.2 Bedside phase-0 efficacy trial for Parkinson disease |
|
|
38 | (12) |
|
|
50 | (4) |
|
|
54 | (7) |
|
|
55 | (1) |
|
|
56 | (5) |
|
Chapter 2 Preparation of Tissue Development --- Mimicking Matrices and Their Applications |
|
|
61 | (16) |
|
|
|
|
|
62 | (1) |
|
|
62 | (3) |
|
3 Stepwise Osteogenesis-Mimicking Matrices |
|
|
65 | (3) |
|
4 Stepwise Adipogenesis-Mimicking Matrices |
|
|
68 | (3) |
|
5 Comparison of Stepwise Osteogenesis-Mimicking and Stepwise Adipogenesis-Mimicking Matrices on Stem Cell Differentiation |
|
|
71 | (2) |
|
|
73 | (4) |
|
|
73 | (4) |
|
Chapter 3 Decellularized Scaffolds: Concepts, Methodologies, and Applications in Cardiac Tissue Engineering and Whole-Organ Regeneration |
|
|
77 | (48) |
|
|
|
|
|
|
|
78 | (3) |
|
2 History and Current State of Decellularized Approach |
|
|
81 | (2) |
|
3 Methodologies in Decellularization Approaches |
|
|
83 | (6) |
|
3.1 The balance between cell removal and ECM preservation |
|
|
83 | (1) |
|
3.2 Current state of decellularization methodologies |
|
|
84 | (1) |
|
|
84 | (2) |
|
|
86 | (1) |
|
3.2.3 Physical methods and preservation methods |
|
|
87 | (1) |
|
3.2.4 Combinations of various decellularization methods |
|
|
87 | (1) |
|
3.2.5 Scaffold treatment --- Sterilization, stabilization, coating, and storage/handling |
|
|
88 | (1) |
|
4 Application of Decellularized Scaffolds in Cardiac Tissue Engineering |
|
|
89 | (8) |
|
4.1 Cardiac tissue engineering |
|
|
89 | (3) |
|
4.2 Acellular myocardial scaffolds and applications |
|
|
92 | (1) |
|
4.3 Biomechanics of acellular myocardial scaffold and its implications |
|
|
93 | (4) |
|
5 Application of Decellularized Scaffolds in Whole-Organ Tissue Engineering |
|
|
97 | (5) |
|
5.1 Demands for whole-organ tissue engineering |
|
|
97 | (1) |
|
5.2 Whole-organ decellularization and its applications |
|
|
98 | (1) |
|
|
99 | (1) |
|
|
99 | (1) |
|
|
100 | (1) |
|
|
101 | (1) |
|
|
102 | (23) |
|
6.1 3D structural integrity |
|
|
102 | (1) |
|
6.2 Recellularization and provision of oxygen and nutrients |
|
|
103 | (4) |
|
|
107 | (1) |
|
|
108 | (1) |
|
|
108 | (17) |
|
Chapter 4 Recent Advances on Three-Dimensional Electrospun Nanofiber Scaffolds for Tissue Regeneration and Repair |
|
|
125 | (38) |
|
|
|
|
|
|
|
126 | (2) |
|
2 Fabrication of 3D Electrospun Nanofiber Scaffolds |
|
|
128 | (16) |
|
2.1 Nanofiber bundles and yarns |
|
|
128 | (3) |
|
2.2 Tubular nanofiber structures |
|
|
131 | (3) |
|
2.3 Microspherical nanofiber structures |
|
|
134 | (1) |
|
2.4 Heterogeneous structures |
|
|
135 | (3) |
|
2.5 Regular structures formed by layer-by-layer stacking |
|
|
138 | (1) |
|
2.6 Regular structures formed by direct fiber writing |
|
|
139 | (1) |
|
2.7 Regular structures with dimpled feature |
|
|
140 | (1) |
|
2.8 Regular structures with patterned hexagonal features |
|
|
141 | (1) |
|
2.9 Regular structures formed by noobing and weaving |
|
|
142 | (2) |
|
3 Utilization of 3D Nanofiber Scaffolds for Tissue Regeneration and Repair |
|
|
144 | (9) |
|
3.1 Putting tubular nanofiber scaffolds to work for artificial blood vessels |
|
|
144 | (2) |
|
3.2 Putting tubular nanofiber scaffolds to work for nerve regeneration |
|
|
146 | (3) |
|
3.3 Putting layer-by-layer stacked nanofiber scaffolds to work for annulus fibrosus regeneration |
|
|
149 | (2) |
|
3.4 Putting 3D nanofiber scaffolds to work for bone regeneration |
|
|
151 | (2) |
|
|
153 | (10) |
|
|
155 | (1) |
|
|
155 | (8) |
|
Chapter 5 Nanofibrous Scaffolds for Tissue Engineering Applications: State-of-the-Art and Future Trends |
|
|
163 | (42) |
|
|
|
|
|
|
|
164 | (2) |
|
|
166 | (33) |
|
2.1 Processing parameters |
|
|
166 | (1) |
|
|
167 | (1) |
|
|
167 | (1) |
|
|
167 | (1) |
|
2.1.4 Types of collectors |
|
|
168 | (1) |
|
|
169 | (1) |
|
2.2.1 Polymer concentration |
|
|
169 | (1) |
|
2.2.2 Solution conductivity |
|
|
170 | (1) |
|
|
170 | (1) |
|
2.3.1 Blends of natural polymers |
|
|
170 | (2) |
|
2.3.2 Blends of natural and synthetic polymers |
|
|
172 | (3) |
|
2.4 State-of-the-art and new trends |
|
|
175 | (1) |
|
2.4.1 Need of electrospinning for tissue engineering |
|
|
175 | (2) |
|
2.4.2 Novel approaches in electrospinning |
|
|
177 | (19) |
|
2.4.3 Combined therapy with drug loaded scaffolds |
|
|
196 | (3) |
|
|
199 | (6) |
|
|
199 | (1) |
|
|
199 | (6) |
|
Chapter 6 Extra Cellular Matrix and Its Application as Coating on Synthetic 3D Scaffolds for Guided Tissue Regeneration |
|
|
205 | (14) |
|
|
|
|
206 | (1) |
|
2 Scaffold-Guided Tissue Regeneration |
|
|
206 | (2) |
|
3 ECM as Naturally Derived Scaffolds |
|
|
208 | (1) |
|
4 Synthetic 3D Scaffolds Coated with Cell Culture Derived ECM for Bone Regeneration |
|
|
209 | (4) |
|
|
213 | (6) |
|
|
214 | (5) |
|
Chapter 7 Nanodimensional and Nanocrystalline Calcium Orthophosphates |
|
|
219 | (124) |
|
|
|
220 | (3) |
|
2 General Information on "Nano" |
|
|
223 | (4) |
|
3 Micron- and Submicron-Sized Calcium Orthophosphates vs. the Nanodimensional Ones |
|
|
227 | (3) |
|
4 Nanodimensional and Nanocrystalline Calcium Orthophosphates in Calcified Tissues of Mammals |
|
|
230 | (3) |
|
|
230 | (2) |
|
|
232 | (1) |
|
5 The Structure of the Nanodimensional and Nanocrystalline Apatites |
|
|
233 | (6) |
|
6 Synthesis of Nanodimensional and Nanocrystalline Calcium Orthophosphates |
|
|
239 | (19) |
|
6.1 General nanotechnological approaches |
|
|
239 | (1) |
|
6.2 Nanodimensional and nanocrystalline apatites |
|
|
240 | (12) |
|
6.3 Nanodimensional and nanocrystalline TCP |
|
|
252 | (1) |
|
6.4 Other nanodimensional and nanocrystalline calcium orthophosphates |
|
|
253 | (4) |
|
6.5 Biomimetic construction using nanodimensional particles |
|
|
257 | (1) |
|
7 Biomedical Applications of Nanodimensional and Nanocrystalline Calcium Orthophosphates |
|
|
258 | (18) |
|
|
258 | (4) |
|
7.2 Nanodimensional and nanocrystalline calcium orthophosphates and cells |
|
|
262 | (4) |
|
|
266 | (2) |
|
7.4 Other biomedical applications |
|
|
268 | (8) |
|
8 Non-Biomedical Applications of the Nanodimensional and Nanocrystalline Calcium Orthophosphates |
|
|
276 | (1) |
|
9 Summary and Perspectives |
|
|
276 | (4) |
|
|
280 | (1) |
|
11 Post-Conclusion Remarks |
|
|
281 | (62) |
|
|
282 | (61) |
|
Chapter 8 Nano-Bioceramics as Coatings for Orthopedic Implants and Scaffolds for Bone Regeneration |
|
|
343 | (50) |
|
Yongxing Liu Mohamed N. Rahaman |
|
|
|
1 Nanotechnology in Orthopedic and Dental Implants |
|
|
344 | (16) |
|
|
346 | (4) |
|
1.2 Nanostructured coatings of bioactive ceramics |
|
|
350 | (1) |
|
1.2.1 Calcium phosphate-based (CaP) coatings |
|
|
351 | (2) |
|
1.2.2 Nanocomposite and doped HA coatings |
|
|
353 | (3) |
|
1.2.3 Reinforcement of HA coatings with nanoscale phases |
|
|
356 | (2) |
|
1.2.4 Non-CaP ceramic coatings |
|
|
358 | (2) |
|
1.3 Outlook for nanostructured ceramic coatings |
|
|
360 | (1) |
|
2 Three-Dimensional Macroporous Scaffolds of Nanostructured Bioceramics |
|
|
360 | (33) |
|
2.1 Bioactive glass scaffolds |
|
|
361 | (3) |
|
|
364 | (3) |
|
|
367 | (2) |
|
2.4 Polymer-ceramic nanocomposites |
|
|
369 | (1) |
|
2.4.1 Nanophase bioactive ceramic coating on macroporous biopolymer scaffolds |
|
|
370 | (1) |
|
2.4.2 Organic-inorganic composites |
|
|
371 | (4) |
|
2.5 Outlook for nanocomposite scaffolds |
|
|
375 | (1) |
|
|
376 | (17) |
|
Chapter 9 Cell Behavior on Electrospun Scaffolds: Factors at Play on Nanoscale |
|
|
393 | (42) |
|
Parthasarathy Madurantakam |
|
|
|
|
394 | (1) |
|
2 Cell Sensing of the Micro-Environment |
|
|
395 | (16) |
|
2.1 Cell-biomaterial interface |
|
|
396 | (1) |
|
|
397 | (1) |
|
2.1.2 Integrin mediated adhesions |
|
|
398 | (2) |
|
2.1.3 Intracellular signaling pathways |
|
|
400 | (1) |
|
|
401 | (2) |
|
2.3 Nano-topologies in electrospun scaffolds |
|
|
403 | (1) |
|
|
403 | (2) |
|
|
405 | (2) |
|
2.3.3 Pore size and porosity |
|
|
407 | (4) |
|
3 Biological Response to Electrospun Scaffolds |
|
|
411 | (1) |
|
4 Physical Substrate for Stem Cell Differentiation |
|
|
412 | (3) |
|
5 Effect of Fiber Diameter and Scaffold Porosity |
|
|
415 | (2) |
|
6 Effect of Fiber Alignment |
|
|
417 | (2) |
|
7 Effect of Chemically Modified Electrospun Scaffolds |
|
|
419 | (5) |
|
|
424 | (11) |
|
|
425 | (10) |
|
Chapter 10 The Convergence of Biomimetic Nanofibers and Cells for Functional Tissue Formation |
|
|
435 | (38) |
|
|
|
|
|
436 | (2) |
|
2 Fabrication of Nanofibers with a Diverse Chemistry |
|
|
438 | (12) |
|
2.1 Synthetic polymer fibers |
|
|
438 | (1) |
|
|
438 | (4) |
|
2.1.2 Poly(lactic-co-glycolic acid) |
|
|
442 | (1) |
|
2.1.3 Other synthetic polymers |
|
|
443 | (1) |
|
2.2 Natural polymer fibers |
|
|
443 | (1) |
|
|
444 | (1) |
|
|
445 | (1) |
|
|
446 | (1) |
|
2.2.4 Other natural polymers |
|
|
447 | (1) |
|
|
448 | (1) |
|
2.3.1 Synthetic polymers with natural polymers |
|
|
448 | (2) |
|
2.3.2 Polymers with ceramics |
|
|
450 | (1) |
|
3 Fiber Dimension and Spatial Arrangement |
|
|
450 | (5) |
|
|
450 | (2) |
|
3.2 Spatial arrangement of electrospun nanofibers |
|
|
452 | (3) |
|
4 Cell-Electrospun Fiber Interaction |
|
|
455 | (5) |
|
|
455 | (1) |
|
4.2 Cell migration and proliferation |
|
|
456 | (1) |
|
|
457 | (2) |
|
|
459 | (1) |
|
5 Future Perspective and Challenge |
|
|
460 | (1) |
|
|
461 | (12) |
|
|
462 | (1) |
|
|
462 | (11) |
|
Chapter 11 Surface Structure of Nanocomposites and Its Properties: A Practical Example |
|
|
473 | (44) |
|
|
|
|
1 The Importance of the Surface in Biomaterials |
|
|
474 | (4) |
|
2 Nano-Composites with Active Surfaces |
|
|
478 | (23) |
|
2.1 Synthesis of nano-sized calcium phosphate apatite |
|
|
480 | (2) |
|
2.2 Preparation of composites having various surface roughness levels |
|
|
482 | (4) |
|
2.3 Characterization of the surface of composite discs (i.e. roughness and hydrophilicity) |
|
|
486 | (3) |
|
|
489 | (3) |
|
2.5 In vitro surface mineralization |
|
|
492 | (3) |
|
2.6 Serum protein adsorption |
|
|
495 | (1) |
|
2.7 rhBMP-2 adsorption from enriched culture medium |
|
|
496 | (1) |
|
|
497 | (2) |
|
2.9 In vivo tissue response |
|
|
499 | (2) |
|
|
501 | (16) |
|
|
507 | (1) |
|
|
508 | (9) |
Index |
|
517 | |